MGC Diagnostics · 18 hours ago
Financial Planning and Analysis Manager
MGC Diagnostics is seeking a Financial Planning & Analysis Manager who will serve as a strategic leader responsible for overseeing the organization's financial planning and analysis functions. This role involves driving financial performance, ensuring robust financial controls, and supporting strategic decision-making through comprehensive analysis and forecasting.
Responsibilities
Lead the development of annual budgets, long-term financial plans, and rolling forecasts
Provide in-depth financial analysis to identify trends, risks, and opportunities
Develop and maintain key performance indicators (KPIs) to monitor financial and operational performance
Prepare and present detailed financial reports and recommendations to executive leadership and stakeholders
Collaborate with senior leadership to develop and execute the organization's financial strategy
Provide insights and guidance on investment decisions, cost management, and resource allocation
Ensure adherence to financial regulations, accounting standards, and internal controls
Lead initiatives to enhance financial governance and reporting accuracy
Oversee the preparation of financial statements and audits in compliance with GAAP/IFRS
Qualification
Required
Bachelor's degree in Finance, Accounting, Economics, or a related field (MBA or CPA preferred)
5+ years of progressive experience in finance, with a focus on FP&A functions
Strong understanding of financial modeling, forecasting, and strategic planning
Exceptional analytical and problem-solving skills with a data-driven mindset
Excellent communication and interpersonal skills, with the ability to influence stakeholders at all levels
Proficiency in financial systems and tools (e.g., ERP systems, financial modeling software)
Preferred
Experience in a global or multi-entity organization
Familiarity with regulatory frameworks and compliance requirements
Company
MGC Diagnostics
MGC Diagnostics develops non-invasive diagnostic systems for detecting and managing cardiorespiratory disease.
Funding
Current Stage
Public CompanyTotal Funding
unknown2022-11-29Acquired
2003-01-17IPO
Recent News
Research and Markets
2025-04-08
Company data provided by crunchbase